TY - JOUR
T1 - Associations of secreted phosphoprotein 1 and B lymphocyte kinase gene polymorphisms with autoimmune thyroid disease
AU - Cheng, Chao Wen
AU - Yang, Shun Fa
AU - Wang, Yuan Hung
AU - Fang, Wen Fang
AU - Lin, Ying Chin
AU - Tang, Kam Tsun
AU - Lin, Jiunn Diann
N1 - Funding Information:
We thank all subjects who participated in the study. This work was supported by a grant from Taipei Medical University and Shuang‐Ho Hospital (105TMU‐SHH‐24).
Funding Information:
We thank all subjects who participated in the study. This work was supported by a grant from Taipei Medical University and Shuang-Ho Hospital (105TMU-SHH-24).
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Background: Dysregulation of the type 1 interferon (IFN)-related signalling pathway predisposes one to autoimmune diseases. Possible associations of single-nucleotide polymorphisms (SNPs) of secreted phosphoprotein 1 (SPP1) and B lymphocyte kinase (BLK) of the type 1 IFN-related signalling pathway with autoimmune thyroid disease (AITD) in an ethnic Chinese (ie Taiwanese) population were tested. Methods: Totally, 83 Hashimoto's thyroiditis (HT) patients, 319 Graves’ disease (GD) patients and 369 controls were enrolled. Genotypes of the two SNPs (rs1126772 and rs1126616) of SPP1 and two SNPs (rs13277113 and rs2736340) of BLK were determined. Results: Our results showed reduced percentages of the G allele of rs13277113 of BLK in GD (P = 0.037, odds ratio [OR] = 0.78, 95% confidence interval [CI] = 0.62-0.99) and HT (P = 0.002, OR = 0.54, 95% CI = 0.36-0.81), compared to the controls. At the same time, lower frequencies of the C allele of rs2736340 of BLK in GD (P = 0.025, OR = 0.76, 95% CI = 0.60-0.97) and HT (P = 0.003, OR = 0.53, 95% CI = 0.35-0.81) than the controls were also observed. There were significantly higher AT haplotype frequencies of rs1327713 and rs2736340 in GD and HT patients than in the controls (P = 0.025, OR = 1.31, 95% CI = 1.03-1.67, and P = 0.003, OR = 1.89, 95% CI = 1.24-2.87, respectively). Moreover, the anti-microsomal antibody titre was associated with rs2736340. Conclusions: Genetic variants of rs13277113 and rs2736340 of BLK were associated with susceptibility to GD, HT and AITD in an ethnic Chinese population. Our results suggest the BLK may participate in the pathogenesis of GD, HT and AITD.
AB - Background: Dysregulation of the type 1 interferon (IFN)-related signalling pathway predisposes one to autoimmune diseases. Possible associations of single-nucleotide polymorphisms (SNPs) of secreted phosphoprotein 1 (SPP1) and B lymphocyte kinase (BLK) of the type 1 IFN-related signalling pathway with autoimmune thyroid disease (AITD) in an ethnic Chinese (ie Taiwanese) population were tested. Methods: Totally, 83 Hashimoto's thyroiditis (HT) patients, 319 Graves’ disease (GD) patients and 369 controls were enrolled. Genotypes of the two SNPs (rs1126772 and rs1126616) of SPP1 and two SNPs (rs13277113 and rs2736340) of BLK were determined. Results: Our results showed reduced percentages of the G allele of rs13277113 of BLK in GD (P = 0.037, odds ratio [OR] = 0.78, 95% confidence interval [CI] = 0.62-0.99) and HT (P = 0.002, OR = 0.54, 95% CI = 0.36-0.81), compared to the controls. At the same time, lower frequencies of the C allele of rs2736340 of BLK in GD (P = 0.025, OR = 0.76, 95% CI = 0.60-0.97) and HT (P = 0.003, OR = 0.53, 95% CI = 0.35-0.81) than the controls were also observed. There were significantly higher AT haplotype frequencies of rs1327713 and rs2736340 in GD and HT patients than in the controls (P = 0.025, OR = 1.31, 95% CI = 1.03-1.67, and P = 0.003, OR = 1.89, 95% CI = 1.24-2.87, respectively). Moreover, the anti-microsomal antibody titre was associated with rs2736340. Conclusions: Genetic variants of rs13277113 and rs2736340 of BLK were associated with susceptibility to GD, HT and AITD in an ethnic Chinese population. Our results suggest the BLK may participate in the pathogenesis of GD, HT and AITD.
KW - autoimmune thyroid disease
KW - B lymphocyte kinase
KW - Graves' disease
KW - Hashimoto’s thyroiditis
KW - secreted phosphoprotein 1
UR - http://www.scopus.com/inward/record.url?scp=85060126780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060126780&partnerID=8YFLogxK
U2 - 10.1111/eci.13065
DO - 10.1111/eci.13065
M3 - Article
AN - SCOPUS:85060126780
SN - 0014-2972
VL - 49
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 3
M1 - e13065
ER -